Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: A review and meta-analysis of published data

Critical Care

Volumn 12, Issue 1, 2008, Pages

  Von Heymann, Christian ^a   Jonas, Sven ^a   Spies, Claudia ^a   Wernecke, Klaus Dieter ^b   Ziemer, Sabine ^a   Janssen, Detlev ^c   Koscielny, Jürgen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SOSTANA GMBH   (Germany)

^c Med i Scene Concept GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; DESMOPRESSIN; FRESH FROZEN PLASMA; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ABDOMINAL SURGERY; ARTICLE; BOLUS INJECTION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DENTAL SURGERY; DISEASE SEVERITY; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; HUMAN; LAPAROTOMY; LIVER TRANSPLANTATION; MAJOR SURGERY; META ANALYSIS; MORBIDITY; NECROTIZING COLITIS; PARTIAL HEPATECTOMY; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROBABILITY; PROPHYLAXIS; PROSTATECTOMY; RISK ASSESSMENT; SURGICAL MORTALITY; SURVIVAL; SYSTEMATIC REVIEW; THROMBOEMBOLISM; UROLOGIC SURGERY; VASCULAR SURGERY; VEIN THROMBOSIS; ABDOMEN; CARDIOVASCULAR SURGERY; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; MORTALITY; PEROPERATIVE COMPLICATION; REVIEW; URINARY TRACT DISEASE;

ABDOMEN; CARDIOVASCULAR SURGICAL PROCEDURES; FACTOR VIIA; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; THROMBOEMBOLISM; UROLOGIC DISEASES;

EID: 40549089223     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6788     Document Type: Article

References (56)

1. Hoffman M Monroe DM A cell-based model of hemostasis Thromb Haemost 2001, 85:958-965. 11434702
2. Lodge JP Jonas S Oussoultzoglou E Malagó M Jayr C Cherqui D Anthuber M Mirza DF Kuhlman L Bechstein WO Díaz JC Tartiere J Eyraud D Fridberg M Erhardtsen E Mimoz O Recombinant coagulation factor VIIa in major liver resection: A randomized, placebo-controlled, double-blind clinical trial Anesthesiology 2005, 102:269-275. 10.1097/ 00000542-200502000-00006 15681939
3. Friederich PW Henny CP Messelink EJ Geerdink MG Keller T Kurth KH Büller HR Levi M Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomised trial Lancet 2003, 361:201-205. 10.1016/S0140-6736(03)12268-4 12547542
4. Agnelli G Bergqvist D Cohen AT Gallus AS Gent M Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery Br J Surg 2005, 92:1212-1220. 10.1002/bjs.5154 16175516
5. Bergqvist D Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery Br J Surg 2004, 91:965-974. 10.1002/bjs.4639 15286956
6. von Depka Prondzinski M Haemorrhagic diatheses Blutgerinnung Bremen London Boston: Uni-Med Verlag von Depka Prondzinski M (Hrsg) 2002, 36-69.
7. Sutton AJ Abrams KR Jones DR Sheldon TA Song F Methods for Meta-Analysis in Medical Research Chichester: John Wiley and Sons 2002.
8. Khan AZ Parry JM Crowley WF McAllen K Davis AT Bonnel BW Hoogeboom JE Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage Am J Surg 2005, 189:331-334. 10.1016/ j.amjsurg.2004.11.021 15792762
9. Clark AD Gordon WC Walker ID Tait RC 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective Vox Sang 2004, 86:120-124. 10.1111/j.0042-9007.2004.00393.x 15023181
10. Manning BJ Hynes N Courtney DF Sultan S Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery Eur J Vasc Endovasc Surg 2005, 30:525-527. 10.1016/j.ejvs.2005.06.021 16099693
11. O'Connell NM Perry DJ Hodgson AJ O'Shaughnessy DF Laffan MA Smith OP Recombinant FVIIa in the management of uncontrolled hemorrhage Transfusion 2003, 43:1711-1716. 10.1046/j.0041-1132.2003.00577.x 14641868
12. Biss TT Hanley JP Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: Use of a clinical scoring system to predict outcome Vox Sang 2006, 90:45-52. 10.1111/j.1423-0410.2005.00711.x 16359355
13. Grounds RM Seebach C Knothe C Paluszkiewicz P Smith TS Kasal E Lecumberri R Urbanec R Haas T Wujtewicz M Rehorkova D Pelichovska M Lange M Uranga M Bosman R Rommes JH Koscielny J Use of recombinant activated factor VII (NovoSeven) in trauma and surgery: Analysis of outcomes reported to an international registry J Intensive Care Med 2006, 21:27-39. 10.1177/0885066605285024 16698742
14. Holcomb JB Neville HL Fischer CF Hoots K Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient Curr Surg 2003, 60:423-427. 10.1016/S0149-7944(02)00690-6 14972234
15. Mayo A Misgav M Kluger Y Geenberg R Pauzner D Klausner J Ben-Tal O Recombinant activated factor VII (NovoSeven): Addition to replacement therapy in acute, uncontrolled and life-threatening bleeding Vox Sang 2004, 87:34-40. 10.1111/j.1423-0410.2004.00533.x 15260820
16. Svartholm E Annerhagen V Lanne T Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor Vlla Anesthesiology 2002, 96:1528. 10.1097/00000542-200206000-00041 12170074
17. Wordliczek J Serednicki W Grabowska I Szczepanik AM Nowak W Popiela T A 43-year-old man was admitted to the hospital with the diagnosis of acute pancreatitis of 4 days' duration Pancreas 2003, 26:101-102. 10.1097/ 00006676-200301000-00020 12499928
18. Aggarwal A Malkovska V Catlett JP Alcorn K Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage Thrombosis J 2004, 2:9. 10.1186/1477-9560-2-9
19. White B McHale J Ravi N Reynolds J Stephens R Moriarty J Smith OP Successful use of recombinant FVIIa (NovoSeven) in the management of intractable post-surgical intra-abdominal hemorrhage Br J Hematol 1999, 107:677-678. 10.1046/j.1365-2141.1999.01798.x
20. Dunkley SM Mackie F Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent Hematology 2003, 8:263-264. 10.1080/10245330310001594252 12911945
21. Gielen-Wijffels SE van Mook WN van der Geest S Ramsay G Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation Intensive Care Med 2004, 30:1232-1234. 10.1007/ s00134-004-2181-0 14985956
22. Michalska-Krzanowska G Sajdak R Stasiak-Pikula E Effects of recombinant factor VIIa in haemorrhagic complications of urological operations Acta Haematol 2003, 109:158-160. 10.1159/000069292 12747373
23. Sander M von Heymann C Kox WJ Spies CD Turk I Loening SA Rückert R Ziemer S Recombinant factor VIIa for excessive bleeding after thrombectomy prior to kidney transplantation Transplantation 2004, 77:1912-1913. 10.1097/01.TP.0000131595.29335.64 15223920
24. Raux M Chiche L Vanhille E Riou B Recombinant activated factor VII to control massive post operative bleeding after septic aortobifemoral grafting Eur J Anaesthesiol 2005, 22:805-807. 10.1017/S026502150526132X 16211789
25. Haas T Innerhofer P Kuhbacher G Fries D Successful reversal of deleterious coagulopathy by recombinant factor VIIa Anesth Analg 2005, 100:54-58. 10.1213/01.ANE.0000138064.12583.F6 15616051
26. Vilstrup H Markiewicz M Biesma D Brozovic VV Laminoga N Malik M Milanov S Patch D Platikanov V Recombinant activated factor VII in an unselected series of cases with upper gastrointestinal bleeding Thromb Res 2006, 118:595-601. 10.1016/j.thromres.2005.10.008 16325890
27. Vlot: AJ Ton E Mackaay AJ Kramer MH Gaillard CA Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII Am J Med 2000, 108:421-422. 10.1016/ S0002-9343(99)00398-8 10759100
28. Chuansumrit A Nuntnarumit P Okascharoen C Teeraratkul S Suwansingh S Supapannachart S The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy Pediatrics 2002, 110:169-171. 10.1542/peds.110.1.169 12093965
29. Filan PM Mills JF Clarnette TD Ekert H Ekert P Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: A potential role for recombinant factor VIIa J Pediatr 2005, 147:857-859. 10.1016/ j.jpeds.2005.07.034 16356448
30. Danilos J Goral A Paluszkiewicz Przesmycki K Kotarski J Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery Obstet Gynecol 2003, 15:1172-1173. 10.1016/ S0029-7844(03)00349-1
31. Girisch M Rauch R Carbon R Habash T Hofbeck M Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: Successful use of recombinant factor VIIa Eur J Pediatr 2004, 163:118-119. 10.1007/s00431-003-1369-6 14716558
32. Schuster R Lee SJ Rink D Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa Am Surg 2003, 69:1017-1018. 14627269
33. Romero-Castro R Jiménez-Sáenz M Pellicer-Bautista F Herrerías-Gutiérrez JM Refractory bleeding after endoscopic sphincterotomy: A new indication for recombinant factor VII therapy? Am J Gastroenterol 2004, 99:2063-2065. 10.1111/ j.1572-0241.2004.40324.x 15447774
34. Laffan MA Tait RC Blatný J Espersen K Grabowska I Loch-Bakoñska L Pauzkowska A Stasiak-Pikula E Michalska G Wendon J Piotrowska K Use of recombinant activated factor VII for bleeding in pancreatitis - A case series Pancreas 2005, 30:279-284. 10.1097/ 01.mpa.0000158026.30925.b4 15782108
35. Vincent JL Rossaint R Riou B Ozier Y Zideman D Spahn DR Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective Crit Care 2006, 10:R120. 1750973 16919168 10.1186/cc5026
36. Levi M Peters M Büller HR Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review Crit Care Med 2005, 33:883-890. 10.1097/01.CCM.0000159087.85970.38 15818119
37. Bui JD Despotis GD Trulock EP Patterson GA Goodnough LT Fatal thrombosis after administration of activated prothrombin complex concentrate in a patient supported by extracorporal membrane oxygenation who had received activated recombinant factor VII J Thorac Cardiovasc Surg 2002, 124:852-854. 10.1067/mtc.2002.126038 12324751
38. MacLaren R Weber LA Brake H Gardner MA Tanzi M A multicenter assessment of recombinant factor VIIa off-label usage: Clinical experiences and associated outcomes Transfusion 2005, 45:1434-1442. 10.1111/ j.1537-2995.2005.00548.x 16131375
39. Meng ZH Wolberg AS Monroe DM 3rd Hoffman M The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients J Trauma 2003, 55:886-891. 14608161
40. Loudon B Smith MP Recombinant factor VIIa as an adjunctive therapy for patients requiring large volume transfusion: A pharmacoeconomic evaluation Intern Med J 2005, 35:463-467. 10.1111/ j.1445-5994.2005.00878.x 16176468
41. Scharrer I Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency Haemophilia 1999, 5:253-259. 10.1046/j.1365-2516.1999.00319.x 10469179
42. von Depka Prondzinski M Acquired haemophilia due to autoantibodies against factor VIII Hamostaseologie 2003, 23:28-35. 12567197
43. Mariani G Konkle BA Ingerslev J Congenital factor VII deficiency: therapy with recombinant activated factor VII - a critical appraisal Haemophilia 2006, 12:19-27. 10.1111/j.1365-2516.2006.01180.x 16409171
44. Poon MC D'Oiron R Von Depka M Khair K Négrier C Karafoulidou A Huth-Kuehne A Morfini M International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey J Thromb Haemost 2004, 2:1096-1103. 10.1111/j.1538-7836.2004.00767.x 15219192
45. Takabe K Holman PR Herbst KD Glass CA Bouvet M Successful perioperative management of factor X deficiency associated with primary amyloidosis J Gastrointest Surg 2004, 8:358-362. 10.1016/j.gassur.2003.10.014 15019934
46. Ciavarella N Schiavoni M Valenzano E Mangini F Inchingolo F Use of recombinant factor FVIIa (NovoSeven®) in the treatment of two patients with Type III von Willebrand's disease and an inhibitor against von Willebrand factor Haemostasis 1996, 26:150-154. 8904191
47. Bosch J Thabut D Bendtsen F D'Amico G Albillos A González Abraldes J Fabricius S Erhardtsen E de Franchis R European Study Group on rFVIIa in UGI Haemorrhage Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial Gastroenterology 2004, 127:1123-1130. 10.1053/ j.gastro.2004.07.015 15480990
48. Almeida AM Khair K Hann I Liesner R The use of recombinant factor VIIa in children with inherited platelet function disorders Br J Haematol 2003, 121:477-481. 10.1046/j.1365-2141.2003.04286.x 12716372
49. Zulfikar B Kayran SM Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven) Blood Coagul Fibrinolysis 2004, 15:261-263. 10.1097/ 00001721-200404000-00011 15060424
50. Kessler CM Antidotes to haemorrhage: Recombinant factor VIIa Best Pract Res Clin Haematol 2004, 17:183-197. 10.1016/j.beha.2004.03.010 15171966
51. Levy JH Fingerhut A Brott T Langbakke IH Erhardtsen E Porte RJ Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: Review of safety profile Transfusion 2006, 46:919-933. 10.1111/ j.1537-2995.2006.00824.x 16734808
52. Raobaikady R Redman J Ball JA Maloney G Grounds RM Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: A double-blind, randomized, placebo-controlled trial Br J Anaesth 2005, 94:586-591. 10.1093/bja/aei102 15734783
53. Shao YF Yang JM Chau GY Sirivatanauksorn Y Zhong SX Erhardtsen E Nivatvongs S Lee PH Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: A multicenter, randomized, double-blind, placebo-controlled trial Am J Surg 2006, 191:245-249. 10.1016/j.amjsurg.2005.10.019 16442954
54. Planinsic RM van der Meer J Testa G Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease Liver Transpl 2005, 11:895-900. 10.1002/ lt.20458 16035081
55. Lodge JP Jonas S Jones RM Olausson M Mir-Pallardo J Soefelt S Garcia-Valdecasas JC McAlister V Mirza DF rFVIIa OLT Study Group Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation Liver Transpl 2005, 11:973-979. 10.1002/lt.20470 16035095
56. Diprose P Herbertson MJ O'Shaughnessy DO Gill RS Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebo-controlled pilot study Br J Anaest 2005, 95:596-602. 10.1093/bja/ aei244